ArticlePloS one2026
Impact of level of nutritional dose and diet specific components of colostrum in promoting 24 h gain, circulating lipid profile, and circulating levels of immunocrit, proteins, glucose, and free amino acids in neonatal gilt piglets.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Colostrum increases DNA fractional synthetic rate, villi growth, and cellular proliferation of the jejunum in neonatal gilt piglets.Translational animal science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colostrum (COL) intake relates to growth trajectory of pigs, which may be driven by differences in nutrient level, bioactive factors, or both. This study's objective was to determine the effect of feeding COL versus milk replacer (MR) at high and low doses [20% or 10% of birth body weight (BBW)] on 24 h weight gain, body temperature, circulating levels of glucose, protein, immunocrit, free amino acids, lipids and small metabolites. At birth, gilt piglets (n = 57) were assigned to: pooled COL fed at 20% (COL20) or 10% of BBW (COL10); MR fed at 20% (MR20) or 10% of BBW (MR10); stay on sow (SOS) to suckle COL; or immediately euthanized at birth (zero hour; ZH). COL20, COL10, MR20, and MR10 were bottle fed diets every 2 h for 24 h, then piglets were euthanized, and blood collected. Serum samples were analyzed for glucose and protein using a colorimetric assay, immunocrit using the immunocrit ratio, free amino acids using liquid chromatography mass spectrometry, and lipidome using multiple reaction monitoring profiling. Dose affected glucose (P = 0.02), being greater in 20% treatments than 10%. Diet and dose impacted immunocrit (P < 0.0001) and protein (P = 0.04), being highest in COL20, intermediate in COL10, and lowest in MR treatments. Diet type impacted all free amino acids (P < 0.05). Diet and dose impacted concentration of triacylglycerols (P = 0.0003), cholesterol esters (diet P = 0.001; dose P = 0.05), and only diet impacted phospholipids (P = 0.04). Diet impacted individual triacylglycerol profile, with fatty acids longer and more unsaturated in COL than MR. Piglets on SOS, COL20, MR20 gained weight and maintained rectal temperature, whereas COL10 and MR10 lost weight and had lower temperatures (P < 0.05). These data and previous studies indicate colostral proteins remain intact post-absorption preventing use for energy. Due to relatively high lactose in MR and circulating metabolite profiles, we postulated piglets fed MR prioritized glycolysis to support growth, whereas COL-fed depended on fatty acid oxidation. Further studies are warranted to understand how absorptive and post-absorptive metabolism respond to diet type and dose and contribute to circulating profiles of nutrients and metabolites.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.